Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate to reduce periprosthetic bone loss after total hip arthroplasty
2010-020215-36Phase 3Completed
- Sponsor
- Servier
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hip osteoarthritis, Aseptic loosening (AL) and Periprosthetic bone loss after total hip arthroplasty (PBL) comparing Strontium ranelate with Placebo (2 arms). Started Jan 2011; status: completed.
02
Drugs
strontium ranelate
03
Conditions
hip osteoarthritisAseptic loosening (AL)Periprosthetic bone loss after total hip arthroplasty (PBL)
Beyond the preview
Go deeper on 2010-020215-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020215-36.